Stockreport

NeuroSense Receives Delisting Notice from Nasdaq and Intends to Appeal

NeuroSense Therapeutics Ltd.  (NRSN) 
PDF CAMBRIDGE, Mass., June 21, 2024 /PRNewswire/ -- NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a company developing novel treatments for severe neurodegener [Read more]